Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Hemispherx, National Institute of Infectious Diseases, Osaka University deal

Biken, the university's Research Foundation for Microbial Diseases, received a non-exclusive license to

Read the full 130 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE